An Evaluation of Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision
Pain, Postoperative, Phimosis, Paraphimosis
About this trial
This is an interventional supportive care trial for Pain, Postoperative focused on measuring penis, pain, ketorolac, circumcision
Eligibility Criteria
Inclusion Criteria:
- All children admitted for circumcision at the Alberta Children's Hospital
Exclusion Criteria:
History of allergic reactions to local anesthetics or ketorolac
- Bleeding diatheses
- Coagulopathy
- Infection at the injection site.
Sites / Locations
- Alberta Children's HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
No ketorolac
Peri-operative ketorolac
15 mg/kg oral dose of acetaminophen is administered prior to surgery. General anesthesia will be induced with sevoflurane via facemask. After establishing venous access, a laryngeal mask will be inserted, and anesthesia maintained with 1 minimum alveolar anesthetic concentration (MAC) of sevoflurane in oxygen/air 50/50 mixture. The DPNB nerve block is done using a 23 GA needle inserted below the Buck fascia. Once the needle tip is positioned appropriately and after a negative aspiration test, 0.2mL/kg (maximum 10mL) of 0.25% bupivacaine is injected in small aliquots, with intermittent aspiration throughout. In all patients, skin incision is performed at least 5 min after placement of the nerve block. Patients will be advised to take ibuprofen and acetaminophen postoperatively as needed.
Exactly same as the no ketorolac group except at the beginning of the circumcision, once the patient is asleep, patients in the perioperative ketorolac group will also receive a 0.5 mg/kg intravenous dose of ketorolac.